Lifetime Modeling For Chronic-Use Switches Advised By U-Penn Researcher
This article was originally published in The Tan Sheet
Executive Summary
Lifetime modeling will be crucial for future Rx-to-OTC switches of chronic-use drugs, Sanford Schwartz, MD, University of Pennsylvania School of Medicine/ The Wharton School, told attendees at a recent CHPA conference